Economic Rules Hub
  • World
  • Politics
  • Business
  • Investing
Home Investing Kameelburg Niobium Assays Reveal up to 9.03% Nb2O5
Investing

Kameelburg Niobium Assays Reveal up to 9.03% Nb2O5

by admin December 27, 2023
December 27, 2023

Aldoro Resources Ltd (“Aldoro”, “The Company”) (ASX: ARN) is pleased to confirm latest niobium results with all six (6) dyke sample assays ranging from 5.8% to 9.03% Nb2O5. These latest results highlight the potential of the area around the periphery of the Kameelburg REE- rich carbonatite, known to contain niobium-rich dykes with historical samples reporting up to 4.75% Nb2O5 (Refer to announcement ASX: ARN 20 March 2023).

HIGHLIGHTS:Latest niobium assays received with results ranging from 5.77% to 9.03% Nb2O5 for all six (6) selected niobium rock chip samplesNiobium samples located within a pyrochlore-rich dyke and has limited exposure due to its presence along the colluvium rich shadow of the giant carbonatite (with diameter spanning 1.4km and rising to 275m in height)Drilling of niobium-rich dyke planned – discussions advancing with experienced local drilling contractorsFurther investigation to proceed on additional dykes and niobium potential along peripheral zones of the Kameelburg Project

Recent investigation at this peripheral dyke revealed an outcrop striking at 315o over 15m, up to 0.5m wide and dipping to the east at 62o. The dyke is located in a nepheline syenite host of the Kameelburg carbonatite and is obscured by colluvium, soil development and vegetation.

Next steps for Aldoro

The Company plans to undertake drilling as part of further investigation into the extent of niobium enrichment within the peripheral dyke. Discussions are advancing with local experienced drill contractors on this front. Aldoro also continues to investigate additional dykes along peripheral zones of the Kameelburg carbonatite, with the intention of unlocking further niobium potential within the entire project region.

Click here for the full ASX Release

This post appeared first on investingnews.com

0
FacebookTwitterPinterestEmail
previous post
Prices finally fell last month after 3.5 years of increases
next post
Top 5 NASDAQ Medical Device Stocks of 2023

Related Posts

Element79 Gold Corp. Comments on Peruvian Government Reform Centralizing Oversight...

May 23, 2025

Purepoint Completes Initial Drill Program Along Groomes Lake Conductive Corridor...

May 23, 2025

Silver47 Announces Graduation to Tier 1 Status on the TSX...

May 23, 2025

Harvest Gold Soil Sampling Program Reveals Several New Gold Targets...

May 23, 2025

Thick High-Grade Graphite Drilling Results In New Zone

May 23, 2025

Group Eleven Announces Uplisting to OTCQB Market

May 23, 2025

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent

    • German tourist carrying ancient Roman artifact on e-scooter chased by Italian police

      May 23, 2025
    • Trump’s image of dead ‘white farmers’ came from Congo, not South Africa

      May 23, 2025
    • Prince William’s new docuseries spotlights ‘one of the most dangerous jobs on the planet’

      May 23, 2025
    • Germany deploys permanent troops to another country for the first time since World War II

      May 23, 2025
    • China says Trump Harvard ban will ‘tarnish’ US image as students caught in crosshairs

      May 23, 2025

    Categories

    • Business (1,368)
    • Investing (3,298)
    • Politics (4,431)
    • World (4,337)
    • Email Whitelisting
    • Terms and Conditions
    • Privacy Policy
    • Contacts
    • About us

    Disclaimer: EconomicRulesHub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 EconomicRulesHub.com | All Rights Reserved

    Economic Rules Hub
    • World
    • Politics
    • Business
    • Investing